V027-6150 Screening compound: N-[1-(cyclohexylcarbamoyl)piperidin-4-yl]-3-(2-methoxybenzamido)pyrazine-2-carboxamide

V027-6150 Screening compound: N-[1-(cyclohexylcarbamoyl)piperidin-4-yl]-3-(2-methoxybenzamido)pyrazine-2-carboxamide
V027-6150 Screening compound: N-[1-(cyclohexylcarbamoyl)piperidin-4-yl]-3-(2-methoxybenzamido)pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V027-6150
N-[1-(cyclohexylcarbamoyl)piperidin-4-yl]-3-(2-methoxybenzamido)pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V027-6150

Molecular Formula

C25H32N6O4 (C25 H32 N6 O4)

Compound Name

N-[1-(cyclohexylcarbamoyl)piperidin-4-yl]-3-(2-methoxybenzamido)pyrazine-2-carboxamide

IUPAC name

N-[1-(cyclohexylcarbamoyl)piperidin-4-yl]-3-(2-methoxybenzamido)pyrazine-2-carboxamide

SMILES

COc(cccc1)c1C(Nc1nccnc1C(NC(CC1)CCN1C(NC1CCCCC1)=O)=O)=O

InChI

InChI=1S/C25H32N6O4/c1-35-20-10-6-5-9-19(20)23(32)30-22-21(26-13-14-27-22)24(33)28-18-11-15-31(16-12-18)25(34)29-17-7-3-2-4-8-17/h5-6,9-10,13-14,17-18H,2-4,7-8,11-12,15-16H2,1H3,(H,28,33)(H,29,34)(H,27,30,32)

InChI Key

CSTCOBYUPAXGDU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19927470

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

480.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.355

Distribution Coefficient, logD

0.186

Water Solubility, LogSw

-3.02

Polar Surface Area

100.929

Acid Dissociation Constant (pKa)

5.23

Base Dissociation Constant (pKb)

2.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.00

V027-6150 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Nucleic Acid Ligands (8311 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V027-6150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V027-6150?
Check Price and Availability of V027-6150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V027-6150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V027-6150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V027-6150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V027-6150 available by request